MyBiotech

Executive Summary

MyBiotech GmbH is a Germany-based Contract Development and Manufacturing Organization (CDMO) specializing in nanomedicine, with a focus on microbiome and infectious disease applications. Founded in 2015 and headquartered in Munich, the company offers end-to-end services including nanoparticle formulation, process development, GMP manufacturing, and aseptic fill-finish. By transforming complex drug molecules into scalable nanomedicines, MyBiotech enables clients to accelerate preclinical and clinical development. As a privately held, pre-clinical stage CDMO, the company leverages its expertise in lipid nanoparticles, polymeric nanoparticles, and other delivery systems to address the growing demand for advanced therapies in infectious disease and microbiome modulation. Although financial data and employee counts are not publicly disclosed, MyBiotech's niche specialization positions it as a key partner for biotech firms seeking to overcome formulation challenges and achieve regulatory-compliant manufacturing. The company's business model is capital-light relative to drug developers, relying on service revenue and potential milestone payments from client partnerships. However, its success is tied to the broader nanomedicine market, which is expanding due to mRNA vaccines, gene therapies, and targeted drug delivery. Key risks include dependence on a limited number of large contracts, competition from larger CDMOs, and regulatory hurdles in sterile manufacturing. Near-term catalysts could include new client announcements, expansion of manufacturing capacity, or adoption of novel nanoparticle platforms. With no disclosed funding rounds or revenue, MyBiotech remains an early-stage service provider with moderate conviction.

Upcoming Catalysts (preview)

• Q3 2026New GMP manufacturing contract with a microbiome-focused biotech60% success
• Q4 2026Announcement of facility expansion for lipid nanoparticle production75% success
• Q2 2026Partnership with an infectious disease vaccine developer50% success